The effect of squalane-dissolved fullerene-C60 on adipogenesis-accompanied oxidative stress and macrophage activation in a preadipocyte-monocyte co-culture system

Biomaterials

Volumn 31, Issue 23, 2010, Pages 5976-5985

  Xiao, Li ^a   Aoshima, Hisae ^b   Saitoh, Yasukazu ^a   Miwa, Nobuhiko ^a  

^a PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^b Vitamin C60 BioResearch Corporation   (Japan)

Author keywords

Adipose tissue engineering; Co culture; Inflammation; Nanoparticle

Indexed keywords

ADIPOCYTES; ADIPOGENESIS; ADIPOGENIC; ADIPOSE TISSUE; CO-CULTURE SYSTEM; COCULTURE; COLLAGEN GELS; INFLAMMATION; INFLAMMATORY DISORDERS; INFLAMMATORY RESPONSE; LIPID DROPLETS; LYMPHOMA CELLS; MACROPHAGE ACTIVATION; MACROPHAGE-LIKE CELLS; METABOLIC SYNDROMES; MONOCYTES/MACROPHAGES; REACTIVE OXYGEN SPECIES; SQUALANE; TISSUE MODELS; U937 CELL;

ANIMAL CELL CULTURE; BODY FLUIDS; DISSOLUTION; DROP FORMATION; FULLERENES; GELS; MACROPHAGES; NANOPARTICLES; OXYGEN; PATHOLOGY; THREE DIMENSIONAL; TISSUE; TISSUE ENGINEERING;

CELL CULTURE;

COLLAGEN GEL; FAT DROPLET; FULLERENE; HYDROCARBON; REACTIVE OXYGEN METABOLITE; SQUALANE; UNCLASSIFIED DRUG; FULLERENE C60; FULLERENE DERIVATIVE; SQUALENE;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL STRAIN U937; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY DISEASE; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; METABOLIC SYNDROME X; MONOCYTE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROADIPOCYTE; ADIPOCYTE; ANIMAL; CELL LINE; CHEMISTRY; METABOLISM; SCANNING ELECTRON MICROSCOPY; TUMOR CELL LINE;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FULLERENES; HUMANS; MACROPHAGE ACTIVATION; MICE; MICROSCOPY, ELECTRON, SCANNING; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SQUALENE;

EID: 77953806722     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.04.032     Document Type: Article

References (39)

1. Hotamisligil Gökhan S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
2. Handschin C., Spiegelman B.M. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008, 454:463-469.
3. Beutler B., Greenwald D., Hulmes J.D., Chang M., Pan Y.C., Mathison J., et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985, 316:552-554.
4. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
5. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
6. Toyoda T., Kamei Y., Kato H., Sugita S., Takeya M., Suganami T., et al. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue. Obesity 2008, 16:1199-1207.
7. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006, 116:1494-1505.
8. Majdalawieh A., Zhang L., Ro H.S. Adipocyte enhancer-binding protein-1 promotes macrophage inflammatory responsiveness by up-regulating NF-kappaB via IkappaBalpha negative regulation. Mol Biol Cell 2007, 18:930-942.
9. Patsouris D., Neels J.G., Fan W., Li P.P., Nguyen M.T., Olefsky J.M. Glucocorticoids and TDZs interfere with adipocyte-mediated macrophage chemotaxis and recruitment. J Biol Chem 2009, 284:31223-31235.
10. Baron P., Constantin G., D'Andrea A., Ponzin D., Scarpini E., Scarlato G., et al. Production of tumor necrosis factor and other proinflammatory cytokines by human mononuclear phagocytes stimulated with myelin P2 protein. Proc Natl Acad Sci U S A 1993, 190:4414-4418.
11. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003, 112:1785-1788.
12. Sartipy P., Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 2003, 100:7265-7270.
13. Emanuelli B., Eberlé D., Suzuki R., Kahn C.R. Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance. Proc Natl Acad Sci U S A 2008, 105:3545-3550.
14. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114:1752-1761.
15. Forman H.J., Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 2002, 166:S4-S8.
16. Shah A., Mehta N., Reilly M.P. Adipose inflammation, insulin resistance, and cardiovascular disease. J Parenter Enteral Nutr 2008, 32:638-644.
17. Barazzoni R., Biolo G., Zanetti M., Bernardi A., Guarnieri G. Inflammation and adipose tissue in uremia. J Ren Nutr 2006, 16:204-207.
18. Dugan L.L., Gabrielsen J.K., Yu S.P., Lin T.S., Choi D.W. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis 1996, 3:129-135.
19. Nielsen G.D., Roursgaard M., Jensen K.A., Poulsen S.S., Larsen S.T. In vivo biology and toxicology of fullerenes and their derivatives. Basic Clin Pharmacol Toxicol 2008, 103:197-208.
20. Xiao L., Takada H., Gan X.H., Miwa N. The water-soluble fullerene derivative ″ Radical Sponge″ exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes. Bioorg Med Chem Lett 2006, 16:1590-1595.
21. Liu Y., Jiao F., Qiu Y., Li W., Lao F., Zhou G., et al. The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity. Biomaterials 2009, 30:3934-3945.
22. Misirkic M.S., Todorovic-Markovic B.M., Vucicevic L.M., Janjetovic K.D., Jokanovic V.R., Dramicanin M.D., et al. The protection of cells from nitric oxide-mediated apoptotic death by mechanochemically synthesized fullerene (C(60)) nanoparticles. Biomaterials 2009, 30:2319-2328.
23. Ryan J.J., Bateman H.R., Stover A., Gomez G., Norton S.K., Zhao W., et al. Fullerene nanomaterials inhibit the allergic response. J Immunol 2007, 179:665-672.
24. Wolins N.E., Quaynor B.K., Skinner J.R., Tzekov A., Park C., Choi K., et al. OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis. J Lipid Res 2006, 47:450-460.
25. Choi H.S., Kim J.W., Cha Y.N., Kim C. A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells. J Immunoassay Immunochem 2006, 27:31-44.
26. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1996, 19:1518-1520.
27. Vettor R., Milan G., Franzin C., Sanna M., De Coppi P., Rizzuto R., et al. The origin of intermuscular adipose tissue and its pathophysiological implications. Am J Physiol Endocrinol Metab 2009, 297. EE9987-98.
28. Colombani A.L., Carneiro L., Benani A., Galinier A., Jaillard T., Duparc T., et al. Enhanced hypothalamic glucose sensing in obesity: alteration of Redox signalling. Diabetes 2009, 58:2189-2197.
29. Ando K., Fujita T. Metabolic syndrome and oxidative stress. Free Radic Biol Med 2009, 47:213-218.
30. Holvoet P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg 2008, 70:193-219.
31. Heilbronn L.K., Campbell L.V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 2008, 14:1225-1230.
32. Goldstein B.J., Mahadev K., Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 2005, 54(2):311-321.
33. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002, 23:599-622.
34. Nakamura S., Takamura T., Matsuzawa-Nagata N., Takayama H., Misu H., Noda H., et al. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem. 2009, 284:14809-14818.
35. Wanner M., Avram M. An evidence-based assessment of treatments for cellulite. J Drugs Dermatol 2008, 7:341-345.
36. Bartosz G. Reactive oxygen species: destroyers or messengers?. Biochem Pharmacol 2009, 77:1303-1315.
37. Lee H., Lee Y.J., Choi H., Ko E.H., Kim J.W. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J Biol Chem 2009, 284:10601-10609.
38. Nakano T., Kodama H., Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 1994, 265:1098-1101.
39. Guo W., Pirtskhalava T., Tchkonia T., Xie W., Thomou T., Han J., et al. Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity. Am J Physiol Endocrinol Metab 2007, 292:E1041-E1051.